the aid library

LIST OPTIONS

Filter

9610

Sort by:

Direction:

Download (415)

View PDF (1186)

The National Integrated Early Childhood Development Policy of Uganda. Popular Version

Ministry of Gender, Labour and Social Development, Uganda (2016) C1

Download (819)

View PDF (1159)

Basic Package of Essential Health Services for Sierra Leone
recommended

Ministry of Health and Sanitation Sierra Leone (2010) C1

Download (6298)

View PDF (4209)

Wound Care For People Affected by Leprosy: A Guide for Low Resource Situations

Hugh Cross American Leprosy Mission (2003)

A Guide for Low Resource Situations

Download (235)

View PDF (596)

Operational Guidelines. Use of Gentamicin by ANMs for management of sepsis in young infants under specific situations

Ministry of Health and Social Welfare, Government of India (2014) C1

Download (238)

View PDF (241)

Health of refugees and migrants. WHO Region Europe 2018

World Health Organization WHO, Regional Office for Europe (2018) C_WHO

Regional situation analysis, practices, experiences, lessons learned and ways forward.

Download (1702)

View PDF (2787)

Clinical Management of HIV in Children and Adults Malawi
recommended

Ministry of Health Malawi; Dept. of HIV and AIDS (2016) C1

Malawi Integrated Guidelines and Standard Operating Procedures for Providing HIV Services. 3rd edition 2016

Download (292)

View PDF (655)

The role of an essential health benefit in the delivery of integrated health services: Learning from practic e in East and Southern Africa

Regional Network for Equity in Health in East and Southern Africa (EQUINET) (2018) C1

Download (262)

View PDF (561)

A Time of Joy, a Time of Challenge: The Health of Mothers & Newborn in Namibia

United Nations Children's Fund (UNICEF) (2009)

A supplement to The State of the World’s Children Report 2009

Download (276)

View PDF (348)

Situation Analysis of Children in Mozambique 2014

UN Children's Fund UNICEF (2015)

Download (363)

View PDF (559)

A Synthesis of Recent Studies on Maternal and Newborn Survival Interventions in Nepal

Child Health Division, Family Health Division, Ministry of Health, Save the Children Nepal (2014) C2

The aim of this report is to: (1) synthesize the findings from selected maternal and newborn related studies in Nepal conducted during 2011-2014, (2) identify areas of improvement in existing interventions, and (3) recommend possible strategies to fulfill such gaps.

Download (815)

View PDF (1199)

Treatment of Drug-Resistant TB with New and Repurposed Medications: A Supplemental Field Guide for Nurses

The SWIFT Response Project (2015) C_WHO

For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al... more

Download (795)

View PDF (1454)

Uganda: Manual for management and control of tuberculosis and leprosy
recommended

Ministry of Health, Republic of Uganda (2017) C2

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

Download (225)

View PDF (275)

Catalogue of Key Eye Health Indicators in the African Region

World Health Organization WHO, Regional Office for Africa (2017) C_WHO

Download (188)

View PDF (145)

The Challenge of Oral Disease.

FDI World Dental Federation (2015) C1

A all for global Action. The Oral Health Atlas. Second edition

Download (102)

View PDF (111)

Checklist and reference list for developing and reviewing a national strategic plan for HIV

UNAIDS (2020) C_WHO

The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response analysis, the NSP development process, the goal, targets and priority-setting of the NSP and the prin... more

Download (55)

View PDF (230)

Community health workers’ efforts to build health system trust in marginalised communities: a qualitative study from South Africa

Watkins, J:W.; F. Griffiths, and J. Goudge BMJ Open (2021) C1

Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ... more

Download (87)

View PDF (1301)

Cancer in sub-Saharan Africa
recommended

Ngwa, W.; et al. Lancet Oncology Commission (2022) C2

Lancet Oncol 2022; 23: e251–312Published OnlineMay 9, 2022 https://doi.org/10.1016/S1470-2045(21)00720-8 In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality. Without rapid interventions, data estimates show a major increase in cancer mo... more

Download (74)

View PDF (121)

WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets

World Health Organisation (WHO) (2022) C_WHO

Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ... more

Download (87)

View PDF (589)

Environmental Stewardship and Climate Action Handbook

World Vision (2023) CC

Climate change presents the single biggest threat to human development, and its widespread impacts disproportionately burden the poorest and most vulnerable households in fragile and rural developing contexts – particularly women and children. According to the Intergovernmental Panel on Climate C... more

Download (239)

View PDF (322)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Basic Package of Essential Health Services for Sierra Leone recommended

Clinical Management of HIV in Children and Adults Malawi recommended

Uganda: Manual for management and control of tuberculosis and leprosy recommended

Cancer in sub-Saharan Africa recommended

Basic Package of Essential Health Services for Sierra Leone
recommended

Clinical Management of HIV in Children and Adults Malawi
recommended

Uganda: Manual for management and control of tuberculosis and leprosy
recommended

Cancer in sub-Saharan Africa
recommended